Clinical Trial Update: Augmentation in Tx-resistant OCD: an Open Label Trial

View source ↗

Summary

A completed open-label trial evaluating augmentation strategies for treatment-resistant obsessive-compulsive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Snippet

Sponsor: Creighton University | Conditions: Obsessive Compulsive Disorder | Status: COMPLETED